<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05944756594572</udiDi>
    <basicUdiDi>B-05944756594572</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1614</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:58.520Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594565</udiDi>
    <basicUdiDi>B-05944756594565</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1613</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:56.120Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594558</udiDi>
    <basicUdiDi>B-05944756594558</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1612</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:54.525Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594541</udiDi>
    <basicUdiDi>B-05944756594541</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1611</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:53.714Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594534</udiDi>
    <basicUdiDi>B-05944756594534</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1610</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:52.114Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594503</udiDi>
    <basicUdiDi>B-05944756594503</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1607</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:49.714Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594527</udiDi>
    <basicUdiDi>B-05944756594527</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1609</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:48.115Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594510</udiDi>
    <basicUdiDi>B-05944756594510</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1608</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:47.430Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594497</udiDi>
    <basicUdiDi>B-05944756594497</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1606</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:31.244Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594480</udiDi>
    <basicUdiDi>B-05944756594480</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1605</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:30.441Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594473</udiDi>
    <basicUdiDi>B-05944756594473</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1604</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:29.640Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594466</udiDi>
    <basicUdiDi>B-05944756594466</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1603</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:28.844Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594459</udiDi>
    <basicUdiDi>B-05944756594459</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1602</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:24.847Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594442</udiDi>
    <basicUdiDi>B-05944756594442</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1601</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:24.045Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594435</udiDi>
    <basicUdiDi>B-05944756594435</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1600</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:23.241Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594428</udiDi>
    <basicUdiDi>B-05944756594428</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1599</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:22.443Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594411</udiDi>
    <basicUdiDi>B-05944756594411</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1598</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:18.446Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594404</udiDi>
    <basicUdiDi>B-05944756594404</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1597</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:17.641Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594398</udiDi>
    <basicUdiDi>B-05944756594398</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1596</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:16.836Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594381</udiDi>
    <basicUdiDi>B-05944756594381</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1595</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:16.049Z</lastUpdated>
  </row>
</eudamedExport>